Stockreport

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF Patients identified across all six TCR-T cohorts in solid tumor program with dosing of first three expected in early May All eight patients in the heme program treate [Read more]